Aktiesnakken — Januar 2012
-
man skal i novo og -zymes sammenhæng holde sig for øje at det er nogle rimelige aggressive multiple de handles til, så der er ikke megen margin for fejl og skuffelser
-
nej jeg er enig med begge udsagn, hvilket kun bekræfter mig i at jeg muligvis har en smule feber
-
iøvrigt vigtig triple a bekræftelse af realkredit danmark
-
jeg vil tro danske bank ånder lettet op
-
det er et ret pænt
-
regnskab, men er 8-13% vækst i diverse nøgletal nok? og så med et forsigtigt outlook?
-
eps = 5,7 = p/e 25?
-
i am just saying. it aint cheap
-
call 911
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind